|
Radiation induced brachial plexopathy
|
C536265 |
|
|
spiro-prorocentrimine
|
C561221 |
|
|
Radiation induced meningioma
|
C536266 |
|
|
CyNE790
|
C561222 |
|
|
Radio renal syndrome
|
C536267 |
|
|
mxd3 protein, Xenopus
|
C561223 |
|
|
Radio-ulnar synostosis type 1
|
C536268 |
|
|
DRB2 protein, Arabidopsis
|
C561224 |
|
|
Ttc8 protein, mouse
|
C561225 |
|
|
N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate
|
C561226 |
|
|
octanedioic acid (1-(3-azido-5-azidomethylbenzyl)-1H-pyrazol-4-yl)amide hydroxyamide
|
C561227 |
|
|
N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide
|
C561228 |
|
|
1-(4-(furo(2,3-b)quinolin-4-ylamino)phenyl)ethanone O-2-aminoethyloxime
|
C561229 |
|
|
Quebec platelet disorder
|
C536260 |
|
|
Limbic Lobe
|
D065726 |
[The medial surface of the cerebral hemisphere around the brain stem.
] |
|
Cytochrome P-450 CYP2C8
|
D065727 |
[A liver microsomal cytochrome P450 hydroxylase that oxidizes a broad spectrum of substrates including STEROIDS, FATTY ACIDS, and XENOBIOTICS. Examples of pharmaceutical substrates for CYP2C8 include; PACLITAXOL; torsemide; and; AMODIAQUINE
] |
|
fatty acid 2-hydroxylase 2, Arabidopsis
|
C575860 |
|
|
Cytochrome P-450 CYP2C9
|
D065729 |
[A cytochrome P-450 subtype that has specificity for acidic XENOBIOTICS. It oxidizes a broad range of important clinical drugs that fall under the categories of NONSTEROIDAL ANTI-INFLAMMATORY AGENTS; HYPOGLYCEMIC AGENTS; ANTCOAGULANTS; and DIURETICS.
] |
|
CML42 protein, Arabidopsis
|
C575861 |
|
|
DIPA protein, mouse
|
C575862 |
|
